A Tie2 kinase mutation causing venous malformations increases phosphorylation rates and enhances cooperativity

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• The endothelial receptor tyrosine kinase Tie2 is crucial for vascular development and stability.
• Mutations in Tie2 cause vascular malformations, characterized by pain, disfigurement, bleeding, and thrombosis.
• The R849W Tie2 mutation is the most frequent cause of inherited vascular malformations and is known to be activating.

Purpose of the Study:

• To investigate the kinetic features of wild-type (WT) and R849W Tie2.
• To understand the catalytic mechanisms underlying the R849W mutation's contribution to vascular malformations.

Main Methods:

• Heterologous expression and purification of WT and R849W Tie2.
• Steady-state kinetic analysis to determine catalytic parameters.
• Comparison of phosphorylation rates and cooperativity between WT and mutant Tie2.

Main Results:

• The catalytic efficiencies (kcat/Km) of WT and R849W Tie2 were not significantly different.
• The maximal rate of phosphorylation (kcat,obs) was over 3-fold higher for R849W Tie2 compared to WT Tie2.
• R849W Tie2 exhibited more pronounced sigmoidal kinetics, indicating enhanced positive cooperativity.

Conclusions:

• The R849W mutation confers activating catalytic features to Tie2, including an increased phosphorylation rate and enhanced cooperativity.
• These altered kinetic properties are likely key contributors to the vascular malformation phenotypes observed in patients.
• Other factors, such as increased protein binding affinity, may also play a role in disease pathogenesis.